58 related articles for article (PubMed ID: 12509940)
1. [Inhibition of tumor growth by a peptide fusion protein binding to vascular endothelial growth factor receptor Flt-1].
Lei H; Shou C; Wu J; Liu X; He L; Liu M; Guo Q; Jiang B
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1342-5. PubMed ID: 12509940
[TBL] [Abstract][Full Text] [Related]
2. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG; Kim TD; Li G; Yoon WH; Chae CB
Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
[TBL] [Abstract][Full Text] [Related]
3. Suppression of tumor growth and metastasis by a VEGFR-1 antagonizing peptide identified from a phage display library.
An P; Lei H; Zhang J; Song S; He L; Jin G; Liu X; Wu J; Meng L; Liu M; Shou C
Int J Cancer; 2004 Aug; 111(2):165-73. PubMed ID: 15197767
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
[TBL] [Abstract][Full Text] [Related]
5. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
6. Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.
Pan B; Li B; Russell SJ; Tom JY; Cochran AG; Fairbrother WJ
J Mol Biol; 2002 Feb; 316(3):769-87. PubMed ID: 11866530
[TBL] [Abstract][Full Text] [Related]
7. [Screening for inhibitor of vascular endothelial growth factor from random peptide library].
Wu J; Zhang H; Wang J; Yang T; Xian J; Yang C; Zheng W; Chen H; Wang Q
Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):540-3. PubMed ID: 12667320
[TBL] [Abstract][Full Text] [Related]
8. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
[TBL] [Abstract][Full Text] [Related]
9. Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis.
Caunt M; Hu L; Tang T; Brooks PC; Ibrahim S; Karpatkin S
Cancer Res; 2006 Apr; 66(8):4125-32. PubMed ID: 16618733
[TBL] [Abstract][Full Text] [Related]
10. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
11. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth.
Fahmy RG; Dass CR; Sun LQ; Chesterman CN; Khachigian LM
Nat Med; 2003 Aug; 9(8):1026-32. PubMed ID: 12872165
[TBL] [Abstract][Full Text] [Related]
12. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
Middeke M; Hoffmann S; Hassan I; Wunderlich A; Hofbauer LC; Zielke A
Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):386-92. PubMed ID: 12518248
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the pro-angiogenic microenvironment by carboxyamido-triazole.
Oliver VK; Patton AM; Desai S; Lorang D; Libutti SK; Kohn EC
J Cell Physiol; 2003 Oct; 197(1):139-48. PubMed ID: 12942550
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
Huh JI; Calvo A; Stafford J; Cheung M; Kumar R; Philp D; Kleinman HK; Green JE
Oncogene; 2005 Jan; 24(5):790-800. PubMed ID: 15592523
[TBL] [Abstract][Full Text] [Related]
16. [Expression of vascular endothelial growth factor and its receptors, flt-1 and kinase insert domain-containing receptor in normal human endometrium during menstrual cycle].
Wang H; Chen G
Zhonghua Fu Chan Ke Za Zhi; 2002 Dec; 37(12):729-32. PubMed ID: 12622916
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis induced by novel peptides selected from a phage display library by screening human vascular endothelial cells under different physiological conditions.
Hardy B; Raiter A; Weiss C; Kaplan B; Tenenbaum A; Battler A
Peptides; 2007 Mar; 28(3):691-701. PubMed ID: 17187899
[TBL] [Abstract][Full Text] [Related]
18. The angiogenic peptide vascular endothelial growth factor (VEGF) is expressed during the remodeling of free tendon grafts in sheep.
Petersen W; Unterhauser F; Pufe T; Zantop T; Südkamp NP; Weiler A
Arch Orthop Trauma Surg; 2003 May; 123(4):168-74. PubMed ID: 12734715
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of tumor angiogenesis by a single-chain antibody directed against vascular endothelial growth factor.
Vitaliti A; Wittmer M; Steiner R; Wyder L; Neri D; Klemenz R
Cancer Res; 2000 Aug; 60(16):4311-4. PubMed ID: 10969766
[TBL] [Abstract][Full Text] [Related]
20. Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors: correlation with microvessel density and clinicopathologic features.
La Rosa S; Uccella S; Finzi G; Albarello L; Sessa F; Capella C
Hum Pathol; 2003 Jan; 34(1):18-27. PubMed ID: 12605362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
